Phathom Pharmaceuticals, Inc. short interest in 2020
In 2020, Phathom Pharmaceuticals, Inc.'s disclosed short interest ran from 3.40% of shares outstanding on 15 Apr 2020 to 2.79% on 31 Dec 2020, a change of -0.61 percentage points. The year's high was 4.30% on 30 Jun 2020 and its low 2.30% on 15 Dec 2020, averaging 3.20% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.07 days on 30 Apr 2020. Full history: Phathom Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 3.40% (15 Apr 2020)
- End of year
- 2.79% (31 Dec 2020)
- Change
- -0.61 pp
- High
- 4.30% (30 Jun 2020)
- Low
- 2.30% (15 Dec 2020)
- Average
- 3.20%
- Highest days to cover
- 32.07 (30 Apr 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Apr 2020 | 3.40% | 18.18 | 10-K filed, results (8-K) |
| 30 Apr 2020 | 3.40% | 32.07 | |
| 15 May 2020 | 3.46% | 23.00 | 10-Q filed, results (8-K) |
| 29 May 2020 | 3.53% | 14.25 | |
| 15 Jun 2020 | 3.51% | 12.75 | |
| 30 Jun 2020 | 4.30% | 7.47 | |
| 15 Jul 2020 | 4.15% | 23.18 | |
| 31 Jul 2020 | 3.66% | 22.09 | |
| 14 Aug 2020 | 3.18% | 22.27 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 3.01% | 23.85 | |
| 15 Sep 2020 | 2.88% | 23.13 | |
| 30 Sep 2020 | 2.82% | 17.47 | |
| 15 Oct 2020 | 2.87% | 16.69 | |
| 30 Oct 2020 | 2.88% | 28.54 | |
| 13 Nov 2020 | 2.77% | 13.10 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 2.63% | 16.19 | |
| 15 Dec 2020 | 2.30% | 9.34 | |
| 31 Dec 2020 | 2.79% | 2.30 |
See also: Phathom Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.